Florinef Shortage
June 6, 2023: Short-term Florinef® shortage announced
Paladin labs has announced a short-term shortage of fludrocortisone acetate (Florinef®), starting today and resolving June 14, 2023. See below for medSask's conservation strategy document.
June 21, 2022 update: Florinef® shortage resolved
The manufacturer reports that the fludrocortisone acetate (Florinef®) shortage is resolved. However, the product is to remain on allocation based on historical demand until end of October to ensure fair distribution.
April 21, 2022: Florinef® shortage announced
Paladin Labs has confirmed that there is currently a shortage of fludrocortisone acetate (Florinef®) due to limited availability and delay in shipment. They anticipate that the shortage will last until May 16, 2022.
With no similar drug available, though not ideal, some patients may need to obtain mineralocorticoid effects with higher doses of hydrocortisone or by switching to hydrocortisone (from prednisone or dexamethasone), as well as consider increasing salt intake. Each patient will need individual adjustments and monitoring if they run out of fludrocortisone.
You can monitor the shortage on the Drugs Shortages Canada site.
If you have concerns, please This email address is being protected from spambots. You need JavaScript enabled to view it.. CSEM will be contacting Health Canada regarding this shortage and the importance of ensuring an uninterrupted supply of this critical drug.
medSask has a helpful conservation strategy document here (updated June 2022):
If you are a patient on fludrocortisone, please consult your physician.